Showing 781 - 800 results of 6,075 for search '"Canada"', query time: 0.06s Refine Results
  1. 781
  2. 782
  3. 783
  4. 784

    A Redescription of the Bulla, Antennae, and Mouth Parts of Female Clavella sp. (Copepoda: Siphonostomatoida: Lernaeopodidae) Infesting Wild Gadus morhua Using Scanning Electron Mic... by Harry M. Murray, Jacqueline M. Hanlon, Kimberly Marshall, Corey Morris

    Published 2020-01-01
    “…This study reports on the occurrence of a lernaeopodid infestation of wild-sourced Gadus morhua sampled from separate inshore (Gilbert Bay, NL) and offshore (Virgin Rocks, NL) populations from Newfoundland, Canada. The majority of the parasites were observed to be associated with the buccal cavity, gill filaments, gill arch, and occasionally near the outer edge of the operculum. …”
    Get full text
    Article
  5. 785

    Prevalence, Demographics, and Treatment Characteristics of Visual Impairment due to Diabetic Macular Edema in a Representative Canadian Cohort by Robert J. Petrella, Julie Blouin, Brian Davies, Martin Barbeau

    Published 2012-01-01
    “…This data can help to inform evaluation of current DME treatment patterns and of proposed new treatment on drug plan budgets in Canada.…”
    Get full text
    Article
  6. 786

    The 5th Canadian Symposium on Hepatitis C Virus: We Are Not Done Yet—Remaining Challenges in Hepatitis C by Nicholas van Buuren, Lorraine Fradette, Jason Grebely, Alexandra King, Mel Krajden, Sonya A. MacParland, Alison Marshall, Sahar Saeed, Joyce Wilson, Marina B. Klein, Selena M. Sagan

    Published 2016-01-01
    “…However, a considerable proportion of the population remains undiagnosed and treatment uptake remains low in Canada due to financial, geographical, cultural, and social barriers. …”
    Get full text
    Article
  7. 787
  8. 788
  9. 789
  10. 790

    Does Vibrio Vulnificus Present a Health Threat to Canadians? by Stanislava Stavric, Barbara Buchanan

    Published 1997-01-01
    “…OBJECTIVE: To review recent data on Vibrio vulnificus and its properties, characteristics of disease and epidemiology, sources of infection, population at risk, infectious dose, documented cases of infection and health risk from V vulnificus infection in Canada.…”
    Get full text
    Article
  11. 791
  12. 792

    Medical Management of Inflammatory Bowel Disease among Canadian Gastroenterologists by J Jones, R Panaccione, ML Russell, R Hilsden

    Published 2011-01-01
    “…BACKGROUND: Little is known about physician perceptions of and practices in using infliximab – a biological agent that was approved in Canada for the treatment of Crohn’s disease in 2001, and for ulcerative colitis in 2006.…”
    Get full text
    Article
  13. 793
  14. 794
  15. 795
  16. 796
  17. 797
  18. 798
  19. 799
  20. 800